Logo 知识与财富的链接
姜黄素自微乳化释药系统处方优化及体外评价

姜黄素自微乳化释药系统处方优化及体外评价

ISSN:1001-2494
2011年第46卷第22期
刘文利1a,1b,张良珂1a,1b*,贾运涛2,袁佩1b,汪程远3,柳静1a LIU Wen-li1a,1b, ZHANG Liang-ke1a,1b*, JIA Yun-tao2, YUAN Pei1b, WANG Cheng-yuan3, LIU Jing1a

 目的 制备姜黄素自微乳化释药系统(Cur-SMEDDS),并考察其体外释药性能。方法 测定姜黄素在各辅料中的溶解度,绘制伪三元相图筛选自微乳化基质,以粒径和溶解度为指标确定最佳处方,并对Cur-SMEDDS的体外释药性质进行研究。结果 Cur-SMEDDS最佳处方组成为:EO-Cremophor RH40-Transcutol P比例为30∶52.5∶17.5,乳化后微乳的平均粒径为36.14 nm。结论 成功制备了Cur-SMEDDS,可显著改善姜黄素的溶解度,有望提高姜黄素的口服生物利用度。

OBJECTIVE To prepare the curcumin self-microemulsifying drug delivery system(Cur-SMEDDS) and study its release characteristics in vitro.METHODS The optimalum formulations of Cur-SMEDDS were screened by solubility experiment,and pseudo-ternary phase diagrams,with average particle size and solubility as parameters.The release curves of Cur-SMEDDS in different release mediuma were measured.RESULTS The optimumal formulation of Cur-SMEDDS was composed of Ethyl oleate/Cremophor RH40/Transcutol P with weight ratio...

认领
收 藏
点 赞
认领进度
0 %

发表评论

ISSN:1001-2494
2011年第46卷第22期

用户信息设置